Prosecution Insights
Prosecution Insights
18 pending office actions • 15 art units • 16 examiners • 0 of 18 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 18 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 18 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 8 (44%) |
| §102 only | 3 (17%) |
| §112 only | 3 (17%) |
| No statute on record | 4 (22%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIN, DANA H | 2 | 27.2% | +27.6% |
| MITCHELL, EDWIN COLEMAN | 2 | 33.3% | +65.1% |
| RODRIGUEZ, CRIS LOIREN | 1 | 20.0% | +9.8% |
| TSAY, MARSHA M | 1 | 45.6% | +52.3% |
| CHO, DAVID H | 1 | 38.2% | +75.0% |
| GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1 | 45.8% | +50.0% |
| MATTHEWS, CHRISTINE HOPKINS | 1 | 71.7% | +30.8% |
| KAPUSHOC, STEPHEN THOMAS | 1 | 46.6% | +52.8% |
| YOUNGBLOOD, WILLIAM JUSTIN | 1 | 63.5% | +38.8% |
| WANG, CHANG YU | 1 | 33.6% | +53.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18033627 | COMPOSITIONS AND METHODS FOR IN VIVO GENE TRANSFER | SHIN, DANA H | 37d overdue |
| 18181226 | NEEDLE-FREE INJECTOR, ASSOCIATED RELOADABLE AND DISPOSABLE NOZZLES, AND METHODS OF INJECTION | RODRIGUEZ, CRIS LOIREN | 37d overdue |
| 18047189 | COMPOSITIONS AND METHODS FOR ENHANCING WEIGHT LOSS | SHIN, DANA H | 2d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17916998 | DECELLULARIZED MENISCAL CARTILAGE AND USES THEROF | MITCHELL, EDWIN COLEMAN | 111d overdue |
| 18176546 | Compositions and Methods for Modulating Factor IX Function | TSAY, MARSHA M | 73d overdue |
| 18033627 | COMPOSITIONS AND METHODS FOR IN VIVO GENE TRANSFER | SHIN, DANA H | 37d overdue |
| 17596622 | USE OF SRRD IN THE INHIBITION OF PROTEIN AGGREGATION | WANG, CHANG YU | 28d overdue |
| 17931184 | System And Method Configured To Provide Extracorporeal Support For Premature Fetus | MATTHEWS, CHRISTINE HOPKINS | 18d overdue |
| 17641665 | COMPOSITIONS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH CLEC16A DYSFUNCTION OR LOSS | YOUNGBLOOD, WILLIAM JUSTIN | 11d overdue |
| 18047189 | COMPOSITIONS AND METHODS FOR ENHANCING WEIGHT LOSS | SHIN, DANA H | 2d overdue |
| 18007407 | NOVEL THERAPEUTIC USES OF COMPOUNDS FOR ENHANCING MITOCHONDRIAL FUNCTION AND TREATING MITOCHONDRIAL DISEASES | CHO, DAVID H | 12d |
| Art Unit | Apps |
|---|---|
| 1635 | 3 |
| 1619 | 2 |
| 3783 | 1 |
| 1656 | 1 |
| 1693 | 1 |
| 1637 | 1 |
| 3791 | 1 |
| 1683 | 1 |
| 1629 | 1 |
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18033627 | COMPOSITIONS AND METHODS FOR IN VIVO GENE TRANSFER | SHIN, DANA H | 1635 | §102 | Non-Final OA | 37d overdue | Pending | Apr 25, 2023 |
| 18181226 | NEEDLE-FREE INJECTOR, ASSOCIATED RELOADABLE AND DISPOSABLE NOZZLES, AND METHODS OF INJECTION | RODRIGUEZ, CRIS LOIREN | 3783 | §103 | Non-Final OA | 37d overdue | Pending | Mar 09, 2023 |
| 18176546 | Compositions and Methods for Modulating Factor IX Function | TSAY, MARSHA M | 1656 | §103 | Final Rejection | 73d overdue | Pending | Mar 01, 2023 |
| 18007407 | NOVEL THERAPEUTIC USES OF COMPOUNDS FOR ENHANCING MITOCHONDRIAL FUNCTION AND TREATING MITOCHONDRIAL DISEASES | CHO, DAVID H | 1693 | Other | Final Rejection | 12d | Pending | Jan 30, 2023 |
| 17970503 | PHYSIOLOGICAL SALINE SOLUTION AND METHODS FOR MAKING AND USING SAME | MITCHELL, EDWIN COLEMAN | 1619 | Other | Final Rejection | 13d | Pending | Oct 20, 2022 |
| 18047189 | COMPOSITIONS AND METHODS FOR ENHANCING WEIGHT LOSS | SHIN, DANA H | 1635 | §102 | Non-Final OA | 2d overdue | Pending | Oct 17, 2022 |
| 17938857 | Compositions and Methods for Treating Huntington's Disease and Related Disorders | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1637 | §102 | Final Rejection | 40d | Pending | Oct 07, 2022 |
| 17916998 | DECELLULARIZED MENISCAL CARTILAGE AND USES THEROF | MITCHELL, EDWIN COLEMAN | 1619 | §103 | Final Rejection | 111d overdue | Pending | Oct 04, 2022 |
| 17931184 | System And Method Configured To Provide Extracorporeal Support For Premature Fetus | MATTHEWS, CHRISTINE HOPKINS | 3791 | §112 | Non-Final OA | 18d overdue | Pending | Sep 12, 2022 |
| 17787433 | NOVEL DRUGGABLE TARGETS FOR THE TREATMENT OF INFLAMMATORY DISEASES SUCH AS SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND METHODS FOR DIAGNOSIS AND TREATMENT USING THE SAME | KAPUSHOC, STEPHEN THOMAS | 1683 | §112 | Final Rejection | 56d | Pending | Jun 20, 2022 |
| 17641665 | COMPOSITIONS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH CLEC16A DYSFUNCTION OR LOSS | YOUNGBLOOD, WILLIAM JUSTIN | 1629 | Other | Final Rejection | 11d overdue | Pending | Mar 09, 2022 |
| 17596622 | USE OF SRRD IN THE INHIBITION OF PROTEIN AGGREGATION | WANG, CHANG YU | 1675 | §112 | Final Rejection | 28d overdue | Pending | Dec 14, 2021 |
| 17594651 | CRISPR/CAS9 GENE EDITING OF ATXN2 FOR THE TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 2 | BABIC, CHRISTOPHER M | 1633 | §103 | Non-Final OA | 8d overdue | Pending | Oct 25, 2021 |
| 17289877 | T CELLS FROM LYMPHATIC FLUID FOR DIAGNOSTIC AND THERAPEUTIC USE | REDDIG, PETER J | 1646 | §103 | Non-Final OA | 30d overdue | Pending | Apr 29, 2021 |
| 17242665 | Cannula Insertion System And Methods Of Using The Same | DANG, ANH TIEU | 3771 | §103 | Non-Final OA | 58d overdue | Pending | Apr 28, 2021 |
| 17272005 | SCALABLE TAGGING OF ENDOGENOUS GENES BY HOMOLOGY-INDEPENDENT INTRON TARGETING | REGA, KYLE THOMAS | 1636 | §103 | Non-Final OA | 16d | Pending | Feb 26, 2021 |
| 17265302 | ALTERNATIVE SPLICING REGULATION OF GENE EXPRESSION AND THERAPEUTIC METHODS | MCLEOD, AFRICA MHAIRIE | 1635 | Other | Final Rejection | 8d overdue | Pending | Feb 02, 2021 |
| 17055075 | CRISPR INTERFERENCE BASED HTT ALLELIC SUPPRESSION AND TREATMENT OF HUNTINGTON DISEASE | NICOL, ALEXANDER W | 1634 | §103 | Final Rejection | 31d overdue | Pending | Nov 12, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial